Table 3 Cost-effectiveness results for universal vaccination vs. no vaccination in a single birth cohort in Oman from birth through age 5 (OMR)
From: Cost effectiveness of a pentavalent rotavirus vaccine in Oman
Cost effectiveness outcome | Payer perspective | Societal perspective |
|---|---|---|
Cost per case avoided, OMR (USD) | 13 (33.8) | Cost saving |
Cost per hospitalization avoided, OMR (USD) | 90 (234) | Cost saving |
Cost per QALY saved, OMR (USD) | 1,140 (2,964) | Cost saving |